Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | GNPAT | O15228 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 2/20 | 0.36 |
| ▸ | GLP1R | P43220 | 8/20 | 0.36 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16231541 | 0.89 | FOLH1 (0.40) | FOLH1GNPATEPHX2ALDH1A1NOD1 | |
| SCHEMBL16234099 | 0.87 | FOLH1 (0.46) | FOLH1GNPATEPHX2NOD1ALB | |
| SCHEMBL16231542 | 0.85 | FOLH1 (0.38) | FOLH1GNPATEPHX2ALDH1A1NOD1 | |
| SCHEMBL25517376 | 0.84 | GNPAT (0.43) | FOLH1GNPATEPHX2NOD1GLP1R | |
| SCHEMBL20235704 | 0.84 | CACNA1B (0.40) | FOLH1GLP1R | |
| SCHEMBL16234090 | 0.84 | FOLH1 (0.43) | FOLH1GNPATEPHX2NOD1ALB | |
| SCHEMBL20235728 | 0.83 | F2 (0.36) | FOLH1EPHX2NOD1GLP1R | |
| SCHEMBL20235802 | 0.83 | FOLH1 (0.36) | FOLH1GNPATEPHX2NOD1ALB | |
| SCHEMBL14932604 | 0.81 | FOLH1 (0.39) | FOLH1GNPATEPHX2NOD1ALB | |
| SCHEMBL16231545 | 0.81 | FOLH1 (0.42) | FOLH1GNPATEPHX2ALDH1A1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10626438-B2 | Fluorescent substrates for determining lysine modifying enzyme activity | THE BROAD INSTITUTE, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| US-20180155760-A1 | FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY | BROAD INST INC (US) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180155760-A1 | FLUORESCENT SUBSTRATES FOR DETERMINING LYSINE MODIFYING ENZYME ACTIVITY | KDM1A, MAN2B1, KDM3A | FOLH1 814/4885GNPAT 2272/4885EPHX2 1831/4885 |
| US-10626438-B2 | Fluorescent substrates for determining lysine modifying enzyme activity | KDM1A, MAN2B1, KDM3A | FOLH1 814/4885GNPAT 2272/4885EPHX2 1831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.